OKYO Pharma Ltd ADR
Quarterly Financials
| Values in thousands | 2023-06-30 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|
Gross Profit | -1 | -1 | -1 |
EBITDA | -3 | -3 | -5,542 |
EBIT | -3 | -3 | -5,543 |
Net Income | -3 | -3 | -5,526 |
Free Cash Flow | -2 | -1 | -3,525 |
Cash | 4,045 | 3,346 | 707 |
Basic Shares | 22 | 22 | 1,406,826 |
Annual Financials
| Values in thousands | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -7 | -3 | -2 | -13 |
EBITDA | -15 | -13,183 | -6,215 | -3,353 |
EBIT | -19 | -13,187 | -6,217 | -3,366 |
Net Income | -16 | -13,271 | -5,431 | -3,353 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -9,490 | -7,701 | -5,469 | -1,607 |
Cash | 826 | 4,045 | 2,700 | 6,889 |
Basic Shares | 29,343 | 22,257 | 979,212 | 672,767 |
Earnings Calls
| Quarter | EPS |
|---|---|
2023-12-31 | $0 |
2023-09-30 | -$0.11 |
2023-06-30 | -$0.34 |
